Research Materials
Semax Peptide Sequence, Structure & ACTH(4–10) Relationship
Semax is a synthetic peptide studied in laboratory research. Understanding its molecular identity begins with its amino-acid sequence and its relationship to adrenocorticotropic hormone (ACTH) fragments.
The commonly reported Semax sequence is MEHFPGP, a chain of seven amino-acid residues. It is related to, but is not identical to, the ACTH(4–10) fragment.
What Is the Semax Peptide Sequence?
Semax is commonly described by the sequence Met–Glu–His–Phe–Pro–Gly–Pro (MEHFPGP). The seven residues are methionine, glutamic acid, histidine, phenylalanine, proline, glycine, and proline.
A peptide containing seven amino-acid residues is called a heptapeptide. The sequence is written from the amino terminus to the carboxyl terminus. This reference sequence is useful when comparing scientific literature and laboratory records.
How Is Semax Related to ACTH(4–10)?
ACTH(4–10) refers to amino-acid positions four through ten of ACTH. Its sequence is commonly given as MEHFRWG, whereas Semax is MEHFPGP.
Both share the first four residues, MEHF, but the last three differ. Semax is therefore described as an ACTH-related analogue, rather than the identical ACTH(4–10) fragment. The sequence distinction matters because studies or analytical results for one molecule cannot automatically be transferred to the other.
Why Do Molecular Structure and Chemical Form Matter?
The order of amino acids defines a peptide's primary structure. Changes in residues or terminal modifications may change molecular mass and analytical behavior.
General chemical databases can provide reference values for a defined Semax structure, but those values do not independently verify the composition of a commercial sample. Salt forms, counterions, hydration, and other sample-specific characteristics should be checked against the actual supplier and laboratory documentation.
Do not infer a current Redline Bio Labs batch's molecular form or test result from a generic reference entry.
How Can Laboratories Evaluate Semax Identity?
High-performance liquid chromatography (HPLC) separates sample components under a defined method and can support assessment of chromatographic purity. A high peak-area percentage, however, is not by itself proof of sequence identity or exact peptide content.
Liquid chromatography–mass spectrometry (LC-MS) can provide molecular-mass evidence supporting identification. Depending on the sample and possible related substances, further sequence-sensitive or complementary methods may be appropriate.
Certificates of analysis (COAs) should connect reported findings to an identifiable sample or batch, describe the methods, and distinguish identity, purity, and content measurements.
Why Is This Important for Research Comparisons?
Semax and ACTH-related peptides appear in experimental literature, but their molecular differences must be respected. Researchers should check the actual sequence, chemical form, experimental conditions, and analytical methods before comparing findings.
Laboratory documentation supports traceability. It does not establish suitability for human or veterinary use.
Frequently Asked Questions
What is the Semax sequence?
The commonly reported reference sequence is MEHFPGP, representing seven amino-acid residues.
Is Semax identical to ACTH(4–10)?
No. ACTH(4–10) is MEHFRWG and Semax is MEHFPGP. They share the first four residues but differ at the final three.
Does HPLC purity confirm Semax identity?
Not on its own. HPLC purity and molecular identity are separate analytical questions.
Does a reference molecular weight verify a product batch?
No. Batch-specific identity and chemical form require relevant analytical documentation.
Explore Semax Research Documentation
Review the Semax product listing and the laboratory reports directory. Confirm that any cited report actually matches the material and batch being evaluated.
For laboratory research use only. Not for human or veterinary consumption.
